Medtronic Chairman & CEO Geoffrey Martha Sells $4.75M in Ordinary Shares Under 10b5-1 Plan

Transaction Summary

On October 15, 2026, Geoffrey Martha, Chairman and Chief Executive Officer of Medtronic plc ($MDT), sold 50,000 ordinary shares at a price of $95.00 per share, generating gross proceeds of $4,750,000.

Key Takeaways

• 10b5-1 Plan Execution: The transaction was executed in accordance with a pre-arranged Rule 10b5-1 trading plan adopted on July 16, 2026, satisfying the required cooling-off period under amended SEC regulations.
• Significance & Context: Although the total disposition exceeds $4.7M, scheduled sales under 10b5-1 plans typically reflect programmatic personal financial planning rather than immediate discretionary sentiment on company performance.
• Remaining Ownership: Following the disposition, Mr. Martha directly retains 277,866 ordinary shares, demonstrating substantial ongoing equity exposure to Medtronic.